JPMorgan's Bill Eigen highlights that markets are more influenced by Donald Trump's social media posts than economic data, with significant market moves often triggered by his comments.
Ken Griffin, founder of Citadel LLC, advises surrounding oneself with smarter minds for career growth. He also warns against being the smartest person in the room.
U.S. stocks advanced across the board by midday Friday, with the S&P 500 eyeing its ninth consecutive day of gains—poised for the longest winning streak since May 2024.
Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers.
According to a Reuters report, Chevron CFO Eimear Bonner said share repurchases in 2025 could be between $11.5 billion and $13 billion, which would be at the lower end of the company's guidance of $10 billion to $20 billion.
Apple and Amazon stocks traded in the red pre-market despite upbeat earnings after citing concerns about the impact of Trump’s tariffs on their financial results.
Billionaire Investor Bill Ackman called on President Donald Trump to temporarily pause tariffs on Chinese imports, arguing such a move would strategically benefit U.S. trade negotiations.
In a potential move towards de-escalation, China's Commerce Ministry is said to be 'assessing' a U.S. offer to discuss the crippling 145% tariffs imposed by President Donald Trump.
The spotlight will likely be on the April non-farm payrolls report. Economists, on average, expect 133,000 job gains for the month, notably slower than the 228,00 pace for March.
China’s spokesperson said if the U.S. wants to talk, it has to show sincerity and be prepared to correct its wrong practices and cancel the unilateral tariffs.
Adial Pharmaceuticals jumped to its highest level since February after receiving a U.S. patent for its precision medicine approach to treating addiction. The patent supports the use of AD04 in patients with specific genetic markers.
